These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 983985)

  • 1. Isoantigen ABH in cervical intraepithelial neoplasia.
    Lill PH; Norris HJ; Rubenstone AI; Chang-Lo M; Davidsohn I
    Am J Clin Pathol; 1976 Nov; 66(5):767-74. PubMed ID: 983985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood group isoantigen and involucrin expression in cervical intraepithelial neoplasia.
    Lindgren A; Stendahl U; Nordlinder H; Busch C
    Anticancer Res; 1987; 7(2):243-6. PubMed ID: 3592638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The study of ABH isoantigen and T (Thomsen-Friedenreich) antigen of superficial urothelial tumor].
    Sasaki K
    Hokkaido Igaku Zasshi; 1984 Nov; 59(6):679-89. PubMed ID: 6530208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood group isoantigen expression during tumour progression of cervical neoplasia.
    Stendahl U; Lindgren A; Busch C
    Anticancer Res; 1987; 7(6):1285-6. PubMed ID: 3442419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A, B & H isoantigens in cervical lesions.
    Bisht D; Misra V; Gupta SC; Mehrotra R; Garg S
    Indian J Pathol Microbiol; 1998 Jan; 41(1):11-4. PubMed ID: 9581070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood group isoantigen deletion in carcinoma in situ of the urinary bladder.
    Weinstein RS; Alroy J; Farrow GM; Miller AW; Davidsohn I
    Cancer; 1979 Feb; 43(2):661-8. PubMed ID: 421187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoantigen loss in cervical neoplasia. Demonstration by immunofluorescence and immunoperoxidase techniques.
    Bonfiglio TA; Feinberg MR
    Arch Pathol Lab Med; 1976 Jun; 100(6):307-14. PubMed ID: 57765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early immunologic diagnosis and prognosis of carcinoma. Philip Levine Award Address.
    Davidsohn I
    Am J Clin Pathol; 1972 Jun; 57(6):715-30. PubMed ID: 5026663
    [No Abstract]   [Full Text] [Related]  

  • 9. Secretor status and ABH antigens expression in patients with oral lesions.
    Campi C; Escovich L; Valdés V; García Borrás S; Racca L; Racca A; Cotorruelo C; Biondi C
    Med Oral Patol Oral Cir Bucal; 2007 Oct; 12(6):E431-4. PubMed ID: 17909508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The distribution of ABO(H) isoantigens in urinary bladder tumours.
    Baranyay F; Knels R; Somogyi L
    Acta Med Hung; 1992-1993; 49(1-2):129-36. PubMed ID: 1296182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical intraepithelial neoplasia.
    Buckley CH; Butler EB; Fox H
    J Clin Pathol; 1982 Jan; 35(1):1-13. PubMed ID: 7037858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathologic spectrum of benign proliferative and intraepithelial neoplastic reactions of the uterine cervix.
    Bonfiglio TA; Patten SF
    J Reprod Med; 1976 May; 16(5):253-62. PubMed ID: 933104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexistence of cervical intraepithelial neoplasia with primary adenocarcinoma of the endocervix.
    Maier RC; Norris HJ
    Obstet Gynecol; 1980 Sep; 56(3):361-4. PubMed ID: 7422175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell surface antigens in squamous cell carcinoma of the oral cavity.
    Das SN; Khanna NN; Khanna S; Gupta S
    J Surg Oncol; 1986 Mar; 31(3):166-9. PubMed ID: 3724169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The concept of cervical intraepithelial neoplasia].
    Dominok GW; Beckert W
    Z Arztl Fortbild (Jena); 1985; 79(22):949-51. PubMed ID: 4096008
    [No Abstract]   [Full Text] [Related]  

  • 16. [The specific erythrocyte adherence method in the study of ABH antigens on normal and neoplastic bladder epithelium].
    Ongaro G; Issi M; Gallo T; Garbeglio A; Ranieri A; Dalla Palma P
    Quad Sclavo Diagn; 1983 Jun; 19(2):242-61. PubMed ID: 6676774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue isoantigens A, B, and H in carcinoma of the cervix uteri: their clinical significance.
    Gupta S; Gupta YN; Singh IJ; Sanyal B; Khanna S; Rani A
    J Surg Oncol; 1981; 16(1):71-7. PubMed ID: 7007740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of ABO(H) isoantigen expression in bladder tumors.
    Srinivas V; Orihuela E; Lloyd KO; Old LJ; Whitmore WF
    J Urol; 1985 Jan; 133(1):25-8. PubMed ID: 3964875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood group antigens in relation to DNA content, S-phase rate and heterogeneity, and their prognostic values in cervical carcinoma.
    Strang P; Lindgren A; Stendahl U
    Anticancer Res; 1987; 7(1):125-8. PubMed ID: 3566178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of keratins 1, 6, 15, 16, and 20 in normal cervical epithelium, squamous metaplasia, cervical intraepithelial neoplasia, and cervical carcinoma.
    Smedts F; Ramaekers F; Leube RE; Keijser K; Link M; Vooijs P
    Am J Pathol; 1993 Feb; 142(2):403-12. PubMed ID: 7679549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.